Clincal Stage | Negative <25% | Weak 25%-50% | Moderate 50%-75% | Strong >75% | Score | P value |
---|---|---|---|---|---|---|
ER/PR(6–5) |  |  | 20(80) | 5(20) | 40 | — |
ER/PR(4–3) | 1(3) | 12(39) | 17(55) | 1(3) | 49 | 0.018 |
ER/PR (2–0) | 1(8) | 6(50) | 5(42) |  | 16 | 0.0007 |
E-cadherin(++/+++) |  | 10(36) | 16(57) | 2(7) | 48 | — |
E-cadherin(+/−) | 2(6) | 20(65) | 9(29) |  | 38 | 0.0003 |
HMW-CK(++/+++) |  | 6(38) | 7(44) | 3(18) | 29 | — |
HMW-CK(+) | Â | 7(58) | 5(42) | Â | 17 | 0.0003 |
HMW-CK(−) | 1(9) | 6(55) | 4(36) |  | 14 | < 0.0001 |